首页 | 本学科首页   官方微博 | 高级检索  
检索        

经支气管动脉输注LAK/IL-2治疗肺癌的免疫指标变化及临床意义
引用本文:梁军,林本耀,赵敬然.经支气管动脉输注LAK/IL-2治疗肺癌的免疫指标变化及临床意义[J].中国肿瘤临床,1996(6).
作者姓名:梁军  林本耀  赵敬然
作者单位:北京肿瘤防治研究所,吉林省人民医院
摘    要:54例原发性肺癌患者经支气管动脉输注LAK/IL-2前后分别测定了体内NK活性、淋转、T细胞亚群及体液免疫指标的变化。结果表明,治疗前体内NK、淋转、OKT3、OKT4均低于正常值,OKT8、C3、IgA、IgM治疗前均高于正常值,治疗后大部分观察指标趋于正常。

关 键 词:肺癌,LAK/IL-2,免疫指标

Significance of Change of Immunological Parameters in Lung Cancer Patient After Infusion of LAK/rIL-2 into Bronchical Artery
Liang Jun, Lin Ben-Yao, Zhao Jing-Ran.Significance of Change of Immunological Parameters in Lung Cancer Patient After Infusion of LAK/rIL-2 into Bronchical Artery[J].Chinese Journal of Clinical Oncology,1996(6).
Authors:Liang Jun  Lin Ben-Yao  Zhao Jing-Ran
Institution:Beijing Institution for Cancer Research
Abstract:The cellular mediated immune function was investigated in 54 cases of primary lung cancer before and after LAK/rIL-2 therapy via bronchial arteryinfusion.The results showed that the levels of NK,lymphocyte blastogenesis test,OKT3,OKT4 were all declined,OKT8,C3,IGA,IGM were all Increased before LAK/rlL-2 Infusion while a majority returned to normal after LAK/rIL-2 treatment.
Keywords:Lung Cancer Intraarterial infusion LAK rIL2
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号